Intrapleural immunotherapy with escalating doses of interleukin-2 in metastatic pleural effusions

Abstract

A daily dose of 10-24 x 10(6) IU/m2/day of IL-2 administered intrapleurally gave response rates similar to those reported in the literature using the intravenous route, but a much lower morbidity rate was recorded.